Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ELI LILLY & Co | 17,611 | reported | 29 Aug 2012 | tx 40+39,252−23,540 |
| OMEROS CORP | 15,000 | reported | 27 Jun 2025 | tx 21+154,500−20,000 |
| Salarius Pharmaceuticals, Inc. | 5,000 | reported | 30 Dec 2025 | tx 19+160,990−27 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Dec 2025 | SALE | Salarius Pharmaceuticals, Inc. | 15 | 0.64 USD | |
| 30 Dec 2025 | SALE | Salarius Pharmaceuticals, Inc. | 12 | 0.64 USD | |
| 20 Nov 2025 | PURCHASE | Salarius Pharmaceuticals, Inc. | 5,000 | 0.75 USD | first after silence |
| 27 Jun 2025 | GRANT_AWARD | OMEROS CORP | 15,000 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | OMEROS CORP | 15,000 | 0.00 USD | deriv |
| 20 Feb 2024 | GRANT_AWARD | Salarius Pharmaceuticals, Inc. | 20,500 | 0.00 USD | deriv |
| 23 Jun 2023 | GRANT_AWARD | OMEROS CORP | 15,000 | 0.00 USD | deriv |
| 22 May 2023 | EXERCISE | OMEROS CORP | 5,000 | 5.30 USD | |
| 22 May 2023 | SALE | OMEROS CORP | 5,000 | 6.46 USD | |
| 22 May 2023 | EXERCISE | OMEROS CORP | 5,000 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | Salarius Pharmaceuticals, Inc. | 1,440 | 0.00 USD | |
| 21 Sept 2022 | GRANT_AWARD | OMEROS CORP | 7,500 | 0.00 USD | deriv |
| 17 Jun 2022 | GRANT_AWARD | OMEROS CORP | 7,500 | 0.00 USD | deriv |
| 03 Jun 2022 | PURCHASE | Salarius Pharmaceuticals, Inc. | 28,000 | 0.18 USD | |
| 11 Jun 2021 | GRANT_AWARD | OMEROS CORP | 7,500 | 0.00 USD | deriv |
| 20 Jan 2022 | GRANT_AWARD | Salarius Pharmaceuticals, Inc. | 30,000 | 0.00 USD | deriv |
| 08 Sept 2021 | EXERCISE | OMEROS CORP | 10,000 | 9.44 USD | |
| 08 Sept 2021 | EXERCISE | OMEROS CORP | 10,000 | 0.00 USD | deriv |
| 10 Aug 2021 | PURCHASE | Salarius Pharmaceuticals, Inc. | 7,000 | 0.88 USD | |
| 02 Dec 2020 | GRANT_AWARD | Salarius Pharmaceuticals, Inc. | 30,000 | 0.00 USD | deriv |
| 21 Aug 2020 | PURCHASE | Salarius Pharmaceuticals, Inc. | 4,000 | 0.98 USD | |
| 05 Jun 2020 | GRANT_AWARD | OMEROS CORP | 7,500 | 0.00 USD | deriv |
| 23 Mar 2020 | GRANT_AWARD | Salarius Pharmaceuticals, Inc. | 6,000 | 0.00 USD | deriv |
| 11 Feb 2020 | PURCHASE | Salarius Pharmaceuticals, Inc. | 4,350 | 0.01 USD | derivanomaly |
| 11 Feb 2020 | PURCHASE | Salarius Pharmaceuticals, Inc. | 4,350 | 1.15 USD |
2 purchases reported after at least 12 months of silence — most recent on 20 Nov 2025.